Metraipolis › archive › dc_e656d4893c6f

Targeting Activated Pathways in Doxorubicin-Resistant TNBC Alters Signaling, Survival and EMT: A Double-Edged Sword — Europe PMC PMID:41898652

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41898652
DOI: 10.3390/ijms27062792
License (as archived): solo-consultazione
Archived: 2026-11-04T05:04:33.966Z
SHA-256 of the archived text: ce7a42dcefbb3a0895d6d57d247b927570a1fb3effc397df43f7560fac4b5f22
Stable URL of this page: https://metraipolis.com/documento/dc_e656d4893c6f

How to cite

Targeting Activated Pathways in Doxorubicin-Resistant TNBC Alters Signaling, Survival and EMT: A Double-Edged Sword — Europe PMC PMID:41898652 — Europe PMC (en), https://europepmc.org/article/MED/41898652 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e656d4893c6f (Metraipolis archive dc_e656d4893c6f, sha256 ce7a42dcefbb3a0895d6d57d247b927570a1fb3effc397df43f7560fac4b5f22)

BibTeX

@misc{dce656d4893c6f,
  title = {Targeting Activated Pathways in Doxorubicin-Resistant TNBC Alters Signaling, Survival and EMT: A Double-Edged Sword — Europe PMC PMID:41898652},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41898652},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e656d4893c6f; sha256 ce7a42dcefbb3a0895d6d57d247b927570a1fb3effc397df43f7560fac4b5f22},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41898652. Agents can read the archived copy with the MCP tool read_document.